This site contains promotional information intended only for healthcare professionals resident in the United Kingdom
Menu
Close
Example of description text sitting alongside header
Example of description text sitting alongside header
Menu
Close
Example of description text sitting alongside header
Example of description text sitting alongside header
Menu
Close
Adverse event reporting can be found at the bottom of the page
Menu
Close
Information on how to access prescribing information and adverse event reporting can be found towards the bottom of the page.
Listen to a selection of short videos where UK and international experts share their views on the role of ZAVICEFTA® (ceftazidime-avibactam), share their clinical experience through patient cases in cUTI, cIAI or HAP/VAP, and in general about the challenges and management of Gram-negative infections.
Francesco De Rosa, Associate Professor of Infectious Diseases, University of Torino, Italy, provides guidance on how to identify seriously ill patients who may acquire an infection due to MDR Gram-negative pathogens. In particular, he shares his perspective on how the following predictive factors – patient fragility, disease severity and the probability of resistance – can be used in clinical practice.
Jean-François Timsit, Professor in Critical care Medicine, in Bichat Hospital, Paris, addresses the importance of treating patients who are at risk of MDR Gram-negative infections early and appropriately. By outlining the consequences of inappropriate antibiotic therapy, this video highlights how delays are shown to lead to longer lengths of stay, higher infection-related mortality and higher healthcare costs.
Dr Andrew Dodgson, Consultant Microbiologist at Manchester, presents on the need for new treatment options at BSAC in 2017.
Dr Andrew Dodgson, Consultant Microbiologist at the Manchester Royal Infirmary discusses the epidemiology of pneumonia and the vital role of susceptibility testing in managing patients.
Abbreviations
cUTI, complicated urinary tract infection, cIAI, complicated intra-abdominal infection; HAP, hospital-acquired pneumonia; VAP, ventilator-associated pneumonia; MDR, multi-drug resistant; BL/BLI, β-lactam/β-lactamase inhibitors; CRE, carbapenem-resistant Enterobacteriaceae; KPC, Klebsiella pneumoniae carbapenemase; OXA, oxacillinase; ESBL, extended-spectrum β-lactamase; AMR, Antimicrobial Resistance
Prescribing information
Click here for ZAVICEFTA® (ceftazidime avibactam) Prescribing Information
Click here for TAZOCIN® (piperacillin sodium, tazobactam sodium) Prescribing Information
Click here for ZINFORO® (ceftaroline fosamil) Prescribing Information
Click here for ZITHROMAX® (azithromycin dihydrate) Prescribing Information
Follow the link to learn about out upcoming meetings and online webinars event - dates, location and agendas.
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search
for MHRA Yellow Card in Google Play or Apple App Store
Adverse events should also be reported to Pfizer Medical Information on 01304 616161
To access further materials, resources and receive communication about medicines and vaccines promoted by Pfizer.
This site is intended only for healthcare professionals resident in the United Kingdom. If you are a member of the public wishing to access information on a specific medicine, please visit www.medicines.org.uk/emc
This website is brought to you by Pfizer Limited, a company registered in England
and Wales under No. 526209 with its registered office at Ramsgate Road, Sandwich, Kent, CT13 9NJ
Copyright © 2024 Pfizer Limited. All rights reserved.
VAT registration number GB201048427
These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.
I confirm that I am a healthcare professional* resident in the United Kingdom.
If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.
*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.
PP-UNP-GBR-7812. January 2024